CT1194D
/ Institute of Hematology and Blood Diseases Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2025
A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China
New P1 trial • Oncology
1 to 1
Of
1
Go to page
1